Ritonavir
CAS No. 155213-67-5
Ritonavir ( A-84538 | ABT-538 )
产品货号. M12207 CAS No. 155213-67-5
一种有效的 HIV 蛋白酶抑制剂,用于治疗 HIV-1 感染。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥251 | 有现货 |
|
| 10MG | ¥365 | 有现货 |
|
| 25MG | ¥583 | 有现货 |
|
| 50MG | ¥834 | 有现货 |
|
| 100MG | ¥1199 | 有现货 |
|
| 200MG | ¥1725 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ritonavir
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种有效的 HIV 蛋白酶抑制剂,用于治疗 HIV-1 感染。
-
产品描述A potent HIV protease inhibitor for treatment of HIV-1 infection; also inhibits cytochrome P450-3A4 (CYP3A4).HIV Infection Approved(In Vitro):Ritonavir (ABT 538) is an inhibitor of CYP3A4 mediated testosterone 6β-hydroxylation with mean Ki of 19 nM and also inhibits tolbutamide hydroxylation with IC50 of 4.2 μM. Ritonavir (ABT 538) is found to be a potent inhibitor of CYP3A-mediated biotransformations (nifedipine oxidation with IC50 of 0.07 mM, 17alpha-ethynylestradiol 2-hydroxylation with IC50 of 2 mM; terfenadine hydroxylation with IC50 of 0.14 mM). Ritonavir is also an inhibitor of the reactions mediated by CYP2D6 (IC50=2.5 mM) and CYP2C9/10 (IC50=8.0 mM). Ritonavir results in an increase in cell viability in uninfected human PBMC cultures. Ritonavir markedly decreases the susceptibility of PBMCs to apoptosis correlated with lower levels of caspase-1 expression, decreases in annexin V staining, and reduces caspase-3 activity in uninfected human PBMC cultures. Ritonavir inhibits induction of tumor necrosis factor (TNF) production by PBMCs and monocytes in a time- and dose-dependent manner at nontoxic concentrations. Ritonavir inhibits p-glycoprotein-mediated extrusion of saquinavir with an IC50 of 0.2 μM, indicating a high affinity of ritonavir for p-glycoprotein. Ritonavir inhibits human liver microsomal metabolism of ABT-378 potently with Ki of 13 nM. Ritonavir combined with ABT-378 (at 3:1 and 29:1 ratios) inhibits CYP3A (IC50=1.1 and 4.6 μM), albeit less potently than Ritonavir (IC50=0.14 μM).
-
体外实验——
-
体内实验——
-
同义词A-84538 | ABT-538
-
通路Microbiology/Virology
-
靶点HIV
-
受体HIVProtease
-
研究领域Infection
-
适应症HIV Infection
化学信息
-
CAS Number155213-67-5
-
分子量720.9442
-
分子式C37H48N6O5S2
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO; H2O:< 0.1 mg/mL
-
SMILESCC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
-
化学全称2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Eagling VA, et al. Br J Clin Pharmacol, 1997, 44(2), 190-194.
2. Zeldin RK, et al. J Antimicrob Chemother. 2004 Jan;53(1):4-9.
产品手册
关联产品
-
YIR-819 TFA salt
YIR-819 是一种小分子 CD4 模拟物,可作为高效的 HIV 进入抑制剂,针对 YTA48P 病毒的 IC50 为 2.6 uM,没有明显的细胞毒性 (CC50=33 uM)。
-
KNI-1657
KNI-1657 (KNI1657) 是一种高效的 HIV-1 蛋白酶抑制剂(1 nM 时抑制率为 97%),对洛匹那韦/利托那韦或达芦那韦耐药菌株具有高敏感性。
-
Fosdevirine
Fosdevirine (GSK2248761) 是一种有效的、选择性的、非核苷类逆转录酶 (reverse transcriptase) 抑制剂 (NNRTI),可抑制人类免疫缺陷病毒 1 型 (HIV-1) 复制,在体外具有低纳摩尔活性。 Fosdevirine 对多种 HIV-1 病毒株显示出良好的活性,包括依非韦伦 (HY-10572) 耐药的临床分离株。
021-51111890
购物车()
sales@molnova.cn

